La jolla pharmaceutical company (LJPC)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash

77,200

87,800

104,800

123,400

140,017

172,604

204,337

241,427

154,408

90,900

120,840

141,317

162,382

65,726

85,035

100,557

113,071

126,467

135,055

36,045

42,712

48,555

54,131

3,888

5,885

8,629

10,700

1,842

2,700

3,405

3,363

3,806

4,381

5,040

5,502

5,792

6,866

Accounts receivable, net

3,552

2,960

1,417

1,893

1,999

1,381

1,537

372

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory, net

1,960

2,211

1,910

1,968

1,977

2,020

1,101

939

820

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

911

910

304

-

200

200

200

237

237

37

37

37

37

37

37

37

37

37

37

0

-

-

-

-

-

-

-

Prepaid clinical expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

105

187

64

223

360

458

1,449

1,528

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

3,383

4,467

4,783

5,089

5,139

5,111

5,847

5,282

6,326

3,147

1,772

1,775

1,687

1,505

1,396

1,356

1,408

618

484

622

622

137

153

148

156

-

47

67

76

25

40

97

50

60

9

19

67

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

-

-

-

-

-

-

-

-

-

-

-

Total current assets

86,114

97,458

112,878

132,396

149,132

181,116

212,822

248,020

161,554

94,062

123,523

144,002

164,373

67,431

86,736

102,300

114,743

127,545

136,136

37,162

44,820

50,257

54,321

4,073

6,078

8,709

10,784

1,946

2,813

3,430

3,403

3,903

4,431

5,100

5,511

5,811

6,933

Property, Plant and Equipment, Net

16,038

18,389

19,523

20,430

21,306

22,267

23,339

24,211

24,438

24,568

6,534

4,585

3,614

3,145

2,566

2,257

2,047

1,732

1,751

1,510

659

279

114

89

51

38

37

37

-

0

-

-

-

-

-

-

-

Right-of-use lease asset

15,146

15,491

15,829

16,159

16,482

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

900

909

-

-

-

909

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted Cash and Cash Equivalents, Noncurrent

-

-

909

909

909

909

909

909

909

909

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

0

0

20

219

219

217

217

70

57

57

57

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

118,207

132,247

149,139

169,894

187,829

204,292

237,070

273,140

186,901

119,539

130,057

148,587

168,007

70,795

89,521

104,774

117,007

129,347

137,944

38,729

45,536

50,536

54,435

4,162

6,129

8,747

10,821

1,983

2,813

3,430

3,403

3,903

4,431

5,100

5,511

5,811

6,933

LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accounts payable

1,895

4,177

5,338

4,908

3,041

8,572

6,570

6,069

7,321

11,484

6,239

5,920

4,173

6,652

1,998

2,256

2,408

3,052

2,567

1,843

2,459

730

683

917

562

834

473

176

69

92

68

129

36

8

23

26

39

Accrued expenses

7,675

9,312

9,351

10,347

9,572

8,485

10,995

6,952

4,280

703

795

488

590

905

3,917

2,112

2,411

678

1,145

285

117

926

900

58

262

187

48

91

176

107

128

89

212

240

151

99

178

Accrued payroll and related expenses

3,649

8,332

5,118

4,080

2,036

7,509

4,922

4,618

3,044

4,995

3,228

1,863

910

2,077

1,321

795

352

1,090

629

410

0

424

32

94

82

73

56

41

26

17

18

12

7

7

83

72

85

Lease liability, current portion

2,828

2,766

2,705

2,646

2,587

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, current portion

-

-

0

0

0

1,370

1,370

1,370

1,370

1,370

-

-

-

124

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,717

13,806

9,417

15,270

2,372

6,677

6,102

Total current liabilities

16,047

24,587

22,512

21,981

17,236

25,936

23,857

19,009

16,015

18,552

10,262

8,271

5,673

9,758

7,236

5,163

5,171

4,820

4,341

2,538

2,576

2,080

1,615

1,069

906

1,094

577

308

271

216

12,931

14,036

9,672

15,525

2,629

6,874

6,404

Lease liability, less current portion

25,745

26,481

27,199

27,890

28,572

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, less current portion

-

-

0

0

0

13,609

13,895

14,161

13,473

12,785

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty obligation, net

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty obligation, net

124,392

124,379

124,366

124,351

124,336

124,323

124,324

124,303

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other noncurrent liabilities

13,692

12,790

10,233

8,265

6,384

4,503

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

179,876

188,237

184,310

182,487

176,528

168,371

162,076

157,473

29,488

31,337

-

-

-

9,758

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series C-12 redeemable convertible preferred stock, $0.0001 par value; 11,000 shares authorized, 5,043 shares issued and outstanding at December 31, 2011, (redemption value and liquidation preference in the aggregate of $5,116 at December 31, 2011, (See Notes 1 and 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,800

5,560

-

5,133

-

-

-

Series C-12 redeemable convertible preferred stock, $0.0001 par value; 11,000 shares authorized, 5,023 and 5,043 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively (redemption value and liquidation preference in the aggregate of $5,282 at March 31, 2012 and $5,116 at December 31, 2011)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,336

-

5,140

5,325

47

Commitments and contingencies (Note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

Shareholders’ deficit:
Common Stock, $0.0001 par value; 100,000,000 shares authorized, 27,276,734 and 27,195,469 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2

2

4

4

4

4

21

3

2

1

5

5

4

-

6

3

0

Series C-12 Convertible Preferred Stock, $0.0001 par value; 11,000 shares authorized, 3,906 shares issued and outstanding at March 31, 2020 and December 31, 2019; and liquidation preference of $3,906 at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,595

3,595

3,607

-

-

-

-

Additional paid-in capital

980,344

977,432

973,018

966,422

959,900

950,258

943,913

933,841

922,809

803,071

796,118

790,351

785,640

661,103

657,464

653,539

650,198

646,408

643,651

535,754

531,873

528,353

525,866

471,087

467,189

462,684

458,796

445,090

443,221

439,672

425,333

422,747

420,156

424,071

424,042

423,485

428,563

Accumulated deficit

-1,045,922

-1,037,331

-1,012,098

-982,924

-952,508

-920,983

-875,565

-824,820

-772,042

-721,514

-682,968

-656,680

-629,951

-606,711

-581,824

-560,573

-545,007

-528,526

-516,693

-506,219

-495,569

-486,614

-479,765

-474,713

-470,429

-465,301

-458,904

-454,730

-451,569

-447,366

-444,261

-442,040

-434,344

-439,629

-426,306

-429,876

-428,081

Total shareholders’ deficit

-61,669

-55,990

-35,171

-12,593

11,301

35,921

74,994

115,667

157,413

88,202

119,795

140,316

162,334

61,037

82,285

99,611

111,836

124,527

133,603

36,191

42,960

48,456

52,820

3,093

5,223

7,653

10,244

1,675

2,542

3,214

-15,328

-15,693

-10,577

-15,558

-2,258

-6,388

482

Total liabilities and shareholders’ deficit

118,207

132,247

149,139

169,894

187,829

204,292

237,070

273,140

186,901

119,539

130,057

148,587

168,007

70,795

89,521

104,774

117,007

129,347

137,944

38,729

45,536

50,536

54,435

4,162

6,129

8,747

10,821

1,983

2,813

3,430

3,403

3,903

4,431

5,100

5,511

5,811

6,933

Series C-1 Convertible Preferred Stock [Member]
Series C-12 Convertible Preferred Stock, $0.0001 par value; 11,000 shares authorized, 3,906 shares issued and outstanding at March 31, 2020 and December 31, 2019; and liquidation preference of $3,906 at March 31, 2020 and December 31, 2019

3,906

3,906

3,906

3,906

3,906

3,906

-

-

-

3,906

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series F Convertible Preferred Stock [Member]
Convertible preferred stock, value

-

-

0

0

0

2,737

-

-

-

2,737

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-